HBW Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Skin Protectant Chafing Indications Should Be Included In Final Rule - CTFA

This article was originally published in The Rose Sheet

Executive Summary

The OTC Skin Protectant Drug Products Final Monograph should include indications for chafing based on conclusions made by FDA in the tentative final monograph, according to the Cosmetic, Toiletry and Fragrance Association
Advertisement

Related Content

Skin Protectant Rule Amended To Include Prevention, Chafing Indications
Skin Protectant Rule Amended To Include Prevention, Chafing Indications
Antiperspirant Duration Claims Limit Revision Sought By CTFA
Skin Protectant Final Rule Allows Cross-Monograph Ingredient Combinations
Skin Protectant Final Rule Allows Cross-Monograph Ingredient Combinations
Advertisement
UsernamePublicRestriction

Register

RS011378

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel